Biomedical Engineer at Unique Instruments & Science Company Limited

Unique Instruments & Science Company Limited is a Nigerian owned corporation that has been distributing medical equipment devices and soft medical supplies to Hospital Laboratories, Medical Centers, Quality Control Laboratories in various sectors, Research Institutes, and other Specialty Laboratories.

We are recruiting to fill the position below:

Job Title: Biomedical Engineer
Location: Fadeyi, Lagos
Employment Type: Full-time

Job Summary

• We are looking for an experienced Biomedical Engineer to join our team as a Field Service Engineer.
• In this crucial role, you will be responsible for ensuring the effective installation, calibration, maintenance, and repair of biomedical and laboratory equipment, all while providing exceptional service to our healthcare clients.

Key Responsibilities

• Perform the installation, calibration, and commissioning of advanced biomedical equipment at client sites.
• Offer expert technical training and support to clients, enhancing their operational capabilities.
• Maintain detailed service records, reports, and documentation of completed work.
• Conduct preventive and corrective maintenance services, ensuring the optimal functionality of medical and laboratory equipment.
• Troubleshoot complex technical issues and provide on-site solutions promptly.

Qualifications

• Bachelor’s Degree in Physics, Biomedical, Electrical, or Mechanical Engineering.
• 2 - 4 years of hands-on experience in biomedical or field service engineering, preferably with medical or laboratory equipment.
• Excellent communication and interpersonal abilities, with a focus on client service.
• Willingness to travel to client locations and manage on-site services.
• Strong analytical, diagnostic, and troubleshooting skills.

Salary
N200,000 - N300,000 monthly.

How to Apply
interested and qualified candidates should send their CV to: careers@uniqueinstrumentsng.com using the Job Title as the subject of the mail

Application Deadline 14th March, 2025.